INDV.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:35):

Stats
Šios dienos apimtis	460 023
Vidutinė apimtis	506 520
Rinkos kapitalizacija	1.91B
EPS	£0 ( 2024-04-24 )
Kita pelno data	( £0 ) 2024-07-25
Last Dividend	£36.50 ( 2016-06-16 )
Next Dividend	£0 ( N/A )
P/E	1 408.00
ATR14	£2.97 (0.21%)

Tūris Koreliacija

Ilgas: 0.16 (neutral)

Trumpas: 0.51 (weak)

Signal:(40.466) Neutral

Indivior PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Indivior PLC Koreliacija - Valiuta/Žaliavos

0.67
( moderate )

0.51
( weak )

-0.25
( neutral )

0.46
( neutral )

0.08
( neutral )

0.24
( neutral )

Indivior PLC Finansinės ataskaitos

Annual	2023
Pajamos:	£1.09B
Bruto pelnas:	£907.00M (82.98 %)
EPS:	£0.0100

FY	2023
Pajamos:	£1.09B
Bruto pelnas:	£907.00M (82.98 %)
EPS:	£0.0100

FY	2022
Pajamos:	£901.00M
Bruto pelnas:	£742.00M (82.35 %)
EPS:	£-0.380

FY	2021
Pajamos:	£791.00M
Bruto pelnas:	£664.00M (83.94 %)
EPS:	£1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£10.40	2015-09-17
Last Dividend	£36.50	2016-06-16
Next Dividend	£0	N/A
Payout Date	2016-07-29
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	£46.90	--
Avg. Dividend % Per Year	0.00%	--
Score	1.12	--
Div. Sustainability Score	4.95
Div.Growth Potential Score	0
Div. Directional Score	1.992	--

Next Divdend (Est)
(2024-07-15)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.12

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TND.L	Dividend Junior	2023-05-11	Semi-Annually	31	1.44%
LUCE.L	Dividend Knight	2023-09-14	Annually	8	2.16%
COST.L	Dividend Knight	2023-09-21	Annually	17	0.27%
RST.L	Dividend Junior	2023-09-21	Annually	13	0.98%
HIK.L	Dividend Knight	2023-08-10	Semi-Annually	19	1.60%
AZN.L	Ex Dividend Knight	2023-08-10	Semi-Annually	32	1.07%
VIC.L	Dividend Knight	2023-06-08	Semi-Annually	2	0.88%
MRO.L	Dividend Junior	2023-09-14	Semi-Annually	19	2.42%
DNA3.L	Dividend Royal	2023-07-20	Quarterly	12	10.69%
SHOE.L	Dividend Knight	2023-07-13	Annually	10	2.57%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00183	1.500	9.96	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00102	1.200	9.97	10.00	[0 - 0.3]
returnOnEquityTTM	0.00542	1.500	-1.051	-1.576	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.968	0.800	-0.161	-0.129	[1 - 3]
quickRatioTTM	0.526	0.800	-1.609	-1.287	[0.8 - 2.5]
cashRatioTTM	0.242	1.500	9.77	10.00	[0.2 - 2]
debtRatioTTM	0.144	-1.500	7.59	-10.00	[0 - 0.6]
interestCoverageTTM	0.553	1.000	-0.906	-0.906	[3 - 30]
operatingCashFlowPerShareTTM	-2.29	2.00	-0.764	-1.528	[0 - 30]
freeCashFlowPerShareTTM	-2.68	2.00	-1.339	-2.68	[0 - 20]
debtEquityRatioTTM	0.215	-1.500	9.14	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.830	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.0192	1.000	-1.616	-1.616	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-1.117	1.000	-7.32	-7.32	[0.2 - 2]
assetTurnoverTTM	0.559	0.800	9.60	7.68	[0.5 - 2]
Total Score				4.95

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	1 208.94	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00542	2.50	-0.676	-1.576	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.68	2.00	-0.892	-2.68	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-2.29	2.00	-0.764	-1.528	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.288	1.000	-9.70	0	[0.1 - 0.5]
Total Score				-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.